AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

CRISPR Therapeutics AG Director's Dealing 2020

Jun 15, 2020

30936_dirs_2020-06-15_c9a6d9ab-29f1-4135-b23e-55ce4c64ff9f.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CRISPR Therapeutics AG (CRSP)
CIK: 0001674416
Period of Report: 2020-06-11

Reporting Person: Treco Douglas A (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	2000	Direct